![](https://nta.org/wp-content/uploads/2023/12/NTA-Opportunities-652x490_3-1-1024x770.webp)
DUE: January 7, 2024
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health.